DOC PREVIEW
UF PHA 5127 - Case Study #4

This preview shows page 1 out of 2 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 2 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 2 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

PHA5127PHA5127 Case Study #4 Fall 2005 1. Jonathan Weasley is put on aminoglycoside therapy and given an i.v. bolus injection of 10mg of drug A, which has a clearance rate equal to the creatinine clearance and a volume of distribution of 26 L. This 34 year old man had a serum creatinine level of 0.6 mg/dL. Jonathan is 5’9’’ and weighs 220 lbs. a. What is his creatinine clearance? b. What is the ke? c. What is the half-life, t1/2? d. What is the Cmax? e. What is the AUC∞? 2. Six other patients are also put on similar therapy and given the same treatment (an i.v. bolus injection of 10 mg of drug A). Please consider the following cases and answer their corresponding questions (Hint. Use the PK simulations for one compartment i.v. bolus models. Also note, that Jonathan had a fu of 0.1, fuT of 0.17, and CLi of 140 L/h): Patient 1: Has the same Vd as Jonathan but has double the clearance rate. Has the following parameters increased, decreased, or stayed the same: i) Cmax, ii) ke, iii) t1/2, and iv) AUC∞? Patient 2: Has the same clearance rate as Jonathan but twice the Vd. Has the following parameters increased, decreased, or stayed the same: i) Cmax, ii) ke, iii) t1/2, and iv) AUC∞? Patient 3: Has the half the clearance rate and Vd as Jonathan. Has the following parameters increased, decreased, or stayed the same: i) Cmax, ii) ke, iii) t1/2, and iv) AUC∞? Patient 4: Is given drug B instead which has half the fraction of drug bound in plasma (in comparison to drug A) but the fraction of drug bound in tissue and the intrinsic clearance is the same. Has the following parameters increased, decreased, or stayed the same: i) Cmax, ii) ke, iii) Vd, iv) CL, v) t1/2, vi) E, vii) F, and viii) AUC∞? Drug B is eliminated by liver only. Patient 5: Is given drug C instead which has twice the intrinsic clearance as drug A (The fraction bound in plasma and tissue is the same as Jonathan’s). Has the following parameters increased, decreased, or stayed the same: i) Cmax, ii) ke, iii) Vd, iv) CL, v) t1/2, vi) E, vii) F, and viii) AUC∞? Drug C is eliminated by the liver only. Patient 6: Is given drug D instead. The drug is eliminated by the kidney only (Note: no tubular reabsorption or secretion occurs). If the fraction of drug unbound in tissue is actually twice than expected, does the following parameters increase, decrease, or staythe same: i) Cmax, ii) ke, iii) Vd, iv) CL, v) t1/2, and vi) AUC∞? Note: the patient has a fu and initial fuT of 0.1 and the clearance is equal to the maximum possible for this


View Full Document

UF PHA 5127 - Case Study #4

Download Case Study #4
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view Case Study #4 and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view Case Study #4 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?